Join the club for FREE to access the whole archive and other member benefits.

Betalin Therapeutics

Develops Engineered Micro-Pancreas (EMP) as a cell therapy solution for insulin-dependent diabetes

Betalin Therapeutics is developing the next generation of insulin-producing cell transplantation providing a solution for insulin-dependent diabetic people using tissue engineering.

Betalin developed a unique  micro organ scaffold that uses natural de-cellularized ECM, derived from natural tissue, to support the long term function of  β-cells.

Visit website: https://betalintherapeutics.com/

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

People at Betalin Therapeutics

Company Representative

CEO at Betalin Therapeutics

Betalin Therapeutics News

Engineered Micro-Pancreas (EMP) could rectify diabetes

Guardian - 23-Jul-2020

Betalin's biological scaffold holds beta cells that release insulin instead of having to inject it

Read more...